295 related articles for article (PubMed ID: 22019750)
21. [Comparison on efficacy and safety of two regimens for treatment of type 2 diabetes mellitus: glargine plus metformin versus neutral protamine hagedorn plus metformin].
Hu M; Luo Y; Zhang L; Yang X; Zhang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):622-5. PubMed ID: 20649032
[TBL] [Abstract][Full Text] [Related]
22. Diabetes medications and cancer: a way out of uncertainty.
Gallo M; Esposito K; Giugliano D
Diabetes Res Clin Pract; 2012 Aug; 97(2):175-7. PubMed ID: 22560795
[No Abstract] [Full Text] [Related]
23. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
25. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
26. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
27. Diabetes, insulin, and risk of cancer.
Schiel R; Beltschikow W; Steiner T; Stein G
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
[TBL] [Abstract][Full Text] [Related]
28. The incidence of congestive heart failure associated with antidiabetic therapies.
Nichols GA; Koro CE; Gullion CM; Ephross SA; Brown JB
Diabetes Metab Res Rev; 2005; 21(1):51-7. PubMed ID: 15386819
[TBL] [Abstract][Full Text] [Related]
29. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
[No Abstract] [Full Text] [Related]
30. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
31. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
[TBL] [Abstract][Full Text] [Related]
32. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
[TBL] [Abstract][Full Text] [Related]
33. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycemia rates with basal insulin analogs.
Little S; Shaw J; Home P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S53-64. PubMed ID: 21668338
[TBL] [Abstract][Full Text] [Related]
35. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
Currie CJ; Johnson JA
Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
[TBL] [Abstract][Full Text] [Related]
36. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
Mehnert H
Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus: influences on cancer risk.
Szablewski L
Diabetes Metab Res Rev; 2014 Oct; 30(7):543-53. PubMed ID: 25044584
[TBL] [Abstract][Full Text] [Related]
38. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and cancer: a consensus report.
Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
[TBL] [Abstract][Full Text] [Related]
40. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
